Joe Basile
Fortuna: 592 799 $ al 30/06/2026
Fortuna: 592 799 $ al 30/06/2026
Mr. Joe Basile is an Independent Non-Executive Director at Neuren Pharmaceuticals Ltd. He is on the Board of Directors at Neuren Pharmaceuticals Ltd. Mr. Basile was previously employed as a Group Chief Financial Officer by iNova Pharmaceuticals (Singapore) Pte Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/03/2026 | 48.206 ( 0,04 % ) | 592 799 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Director/Miembro de la Junta | 02/03/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
iNova Pharmaceuticals (Singapore) Pte Ltd.
iNova Pharmaceuticals (Singapore) Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Neuren Pharmaceuticals Ltd.
Neuren Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Manufactures drugs for neurological disorders | Health Technology |
iNova Pharmaceuticals (Singapore) Pte Ltd.
iNova Pharmaceuticals (Singapore) Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.